Perrigo (PRGO) Assets Average (2013 - 2026)
Perrigo (PRGO) posted quarterly Assets Average of $8.3 billion for Q1 2026, down 14.89% year-over-year from $9.7 billion in Q1 2025, and down 11.28% quarter-over-quarter from $9.3 billion in Q4 2025.
Perrigo (PRGO) Assets Average (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Assets Average for 14 consecutive years, with $8.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 14.89% year-over-year to $8.3 billion; the TTM figure through Mar 2026 stood at $8.3 billion (down 14.89% YoY), while the FY2025 annual figure was $9.1 billion, down 11.12% from the prior year.
- Assets Average fell to $8.3 billion in Q1 2026 per PRGO's latest filing, from $9.3 billion in the prior quarter.
- Across five years, Assets Average topped out at $11.0 billion in Q2 2023 and bottomed at $8.3 billion in Q1 2026.
- Historically, Assets Average has averaged $10.4 billion across 5 years, with a median of $10.7 billion in 2022.
- Annual changes were most pronounced in 2023 — Assets Average increased 5.56% — and 2026, when it fell 14.89%.
- Perrigo's Assets Average stood at $10.8 billion in 2022, then slipped by 0.59% to $10.8 billion in 2023, then dropped by 3.32% to $10.4 billion in 2024, then slipped by 10.7% to $9.3 billion in 2025, then decreased by 11.28% to $8.3 billion in 2026.
- Business Quant data shows PRGO's Assets Average at $8.3 billion in Q1 2026, $9.3 billion in Q4 2025, and $10.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 7.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 7.80 Bn |
| Mar 28, 2026 | 8.26 Bn |
| Dec 31, 2025 | 9.31 Bn |
| Sep 27, 2025 | 10.09 Bn |
| Jun 28, 2025 | 9.93 Bn |
| Mar 29, 2025 | 9.70 Bn |
| Dec 31, 2024 | 10.43 Bn |
| Sep 28, 2024 | 10.80 Bn |
| Jun 29, 2024 | 10.52 Bn |
| Mar 30, 2024 | 10.72 Bn |
| Dec 31, 2023 | 10.78 Bn |
| Sep 30, 2023 | 10.86 Bn |
| Jul 1, 2023 | 10.96 Bn |
| Apr 1, 2023 | 10.99 Bn |
| Dec 31, 2022 | 10.85 Bn |
| Oct 1, 2022 | 10.80 Bn |
| Jul 2, 2022 | 10.65 Bn |
| Apr 2, 2022 | 10.41 Bn |
| Dec 31, 2021 | 10.67 Bn |
| Oct 2, 2021 | 11.07 Bn |